INM vs LW · rev $4.9M vs P/E 21, rev $6.61B
InMed Pharmaceuticals Inc (INM) versus Lamb Weston Holdings Inc (LW) — a side-by-side from cached financials, not a winner call.
InMed Pharmaceuticals Inc (INM) is a drug manufacturers - specialty & generic company listed on US.
Lamb Weston Holdings Inc (LW) is a packaged foods company listed on US.
Latest reported INM revenue for 2025-06-30 was $4.9M. Net income was -$8.2M. INM currently screens at market cap $5.2M.
Latest reported LW revenue for 2026-05-31 was $6.61B. Net income was $290.0M. Revenue was up 2.5% from 2025-05-25 to 2026-05-31. LW currently screens at market cap $7.40B and trailing P/E 20.6.
INM currently screens at market cap $5.2M. LW currently screens at market cap $7.40B and trailing P/E 20.6.
Not investment advice. Open the INM and LW stock pages for the full models.
Not investment advice.